News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
The clinical trial technology and specialty services provider has announced Amir Kalali, MD, as executive advisor for global strategy (image left). He was previously the global head of the Neuroscience Center of Excellence at Quintiles IMS.
“I have been working for a long time on improving outcomes in clinical trials and will be working to help identify the best new approaches to making sure drug development is working better. I will be especially focused on all of the new, emerging technologies we are seeing in research, and ensuring these are leveraged in the best possible way for patients and investigators,” Kalali told us.
Kalali will work with Bracket's leadership to help identify innovative technologies to support the company’s continued growth.
Bracket has also hired Greenphire’s co-founder and former CEO Sam Whitaker (image right) as its new chief technology officer (CTO).
As CTO, Whitaker will be responsible for Bracket’s global product strategy, management and innovation, technology development, and engineering
“In my new role as Bracket’s Chief Technology Officer, I hope to be innovative,” Whitaker told Outsourcing-Pharma.com.
“I want to do things differently. I want to create things that has never existed before. I want to embrace a culture of innovation within Bracket and creates environments in which employees, clients, users and the industry are given the tools and resources they need to challenge the status quo, push boundaries and achieve growth for the benefit of the patients of the world.